Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Similar Posts
Smoking shrinks the brain and drives up Alzheimer’s risk, new study finds
Smoking is notorious for causing damage to the lungs — but a recent study confirmed that it’s also harmful to the brain. Researchers from the Washington University School of Medicine (WashUMed) in St. Louis, Missouri, analyzed the brain scans, smoking history and genetic risk of 32,094 participants of European descent from the UK Biobank database….
Cigna explores shedding Medicare Advantage business | Reuters News Agency
DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.  Market Impact…
Thousands of doses of childhood vaccines reportedly transported into Gaza Strip through Rafah crossing
Thousands of doses of vaccines against childhood diseases have started to be delivered into the Gaza Strip to support a growing health emergency in the region, the Palestinian health ministry in the Hamas-controlled government announced Monday. The vaccines to treat childhood diseases, including polio and measles, are estimated to be enough to cover vaccinations for…
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…
Asia’s year in review: Who had it good — and who had it bad — in 2023
Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…
